Cambridge Investment Research Advisors, Inc. Vericel Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 26, 2024	SELL	$41.71 - $52.9 $5,046 - $6,400	-121 Reduced 2.69%	4,383 $201,000
Q1 2024 Apr 24, 2024	SELL	$32.52 - $52.33 $184,388 - $296,711	-5,670 Reduced 55.73%	4,504 $234,000
Q4 2023 Feb 09, 2024	SELL	$30.85 - $37.09 $282,832 - $340,041	-9,168 Reduced 47.4%	10,174 $362,000
Q3 2023 Oct 24, 2023	SELL	$31.69 - $39.25 $19,806 - $24,531	-625 Reduced 3.13%	19,342 $648,000
Q2 2023 Jul 13, 2023	SELL	$29.0 - $38.37 $39,150 - $51,799	-1,350 Reduced 6.33%	19,967 $750,000
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $2,814 - $3,698	118 Added 0.56%	21,317 $625,000
Q4 2022 Feb 08, 2023	SELL	$17.65 - $27.37 $6,230 - $9,661	-353 Reduced 1.64%	21,199 $558,000
Q3 2022 Oct 17, 2022	SELL	$22.62 - $32.54 $4,388 - $6,312	-194 Reduced 0.89%	21,552 $500,000
Q2 2022 Jul 13, 2022	SELL	$22.88 - $39.45 $12,263 - $21,145	-536 Reduced 2.41%	21,746 $547,000
Q1 2022 May 12, 2022	SELL	$31.69 - $43.29 $11,947 - $16,320	-377 Reduced 1.66%	22,282 $851,000
Q4 2021 Feb 03, 2022	BUY	$35.2 - $52.6 $24,816 - $37,083	705 Added 3.21%	22,659 $890,000
Q3 2021 Nov 02, 2021	BUY	$46.35 - $59.75 $32,305 - $41,645	697 Added 3.28%	21,954 $1.07 Million
Q2 2021 Aug 10, 2021	SELL	$47.2 - $67.81 $8,071 - $11,595	-171 Reduced 0.8%	21,257 $1.12 Million
Q1 2021 May 07, 2021	BUY	$30.93 - $59.48 $12,835 - $24,684	415 Added 1.97%	21,428 $1.19 Million
Q4 2020 Feb 04, 2021	BUY	$18.53 - $31.5 $1,111 - $1,890	60 Added 0.29%	21,013 $648,000
Q3 2020 Oct 29, 2020	SELL	$14.68 - $19.12 $74,868 - $97,512	-5,100 Reduced 19.58%	20,953 $388,000
Q2 2020 Jul 27, 2020	SELL	$8.5 - $15.82 $1,062 - $1,977	-125 Reduced 0.48%	26,053 $360,000
Q1 2020 May 08, 2020	BUY	$7.25 - $19.22 $29,493 - $78,186	4,068 Added 18.4%	26,178 $240,000
Q4 2019 Feb 04, 2020	BUY	$13.77 - $19.2 $36,091 - $50,323	2,621 Added 13.45%	22,110 $384,000
Q3 2019 Nov 06, 2019	BUY	$14.93 - $19.83 $44,401 - $58,974	2,974 Added 18.01%	19,489 $295,000
Q2 2019 Aug 15, 2019	BUY	$15.01 - $18.89 $84,821 - $106,747	5,651 Added 52.02%	16,515 $0
Q1 2019 May 08, 2019	BUY	$16.23 - $20.29 $176,322 - $220,430	10,864 New	10,864 $0

Others Institutions Holding VCEL

# of Institutions

293

Shares Held

50.7M

Call Options Held

98.2K

Put Options Held

135K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.3B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account